← Leaderboards
Cobi J Heijnen
University Of Tx Md Anderson Can Ctr
$4,217,788
Attributed
$9,258,910
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2014–23$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,258,910 · 6
By mechanism
R01$8,876,110 · 5
R21$382,800 · 1
Top collaborators
- Annemieke Kavelaars13 shared
- Robert Dantzer8 shared
- Daniela Salvemini4 shared
- Peter M Grace2 shared
- Andrew John Shepherd1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Peter M Grace$7,419,176
- Andrew John Shepherd$7,386,853
- Varsha Gandhi$2,500,715
- Shao-Rui Chen$3,356,636
- Hui-Lin Pan$27,634,836
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainChemotherapyCellsNeuroinflammationInnovationMouse ModelCisplatinInflammatoryMolecularNeuronsFda ApprovedPublic HealthBasePreventIn VivoDoseMediatingImpaired CognitionChemobrainDensityWhite MatterPeripheralPharmaceutical PreparationsNovel Strategies
Grant awards (22)
Regulation of Peripheral Neuropathic Pain by B Cells$626,592
R01 · FY2023 · NS
Regulation of Peripheral Neuropathic Pain by B Cells$621,493
R01 · FY2022 · NS
A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity$565,356
R01 · FY2021 · CA
A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity$565,356
R01 · FY2020 · CA
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$403,504
R01 · FY2020 · NS
Mesenchymal Stem Cells to Repair Chemobrain$402,051
R01 · FY2020 · CA · contact PI
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain$366,766
R01 · FY2020 · CA
A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity$548,396
R01 · FY2019 · CA
Mesenchymal Stem Cells to Repair Chemobrain$389,989
R01 · FY2019 · CA · contact PI
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$375,286
R01 · FY2019 · NS
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain$355,763
R01 · FY2019 · CA
A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity$578,231
R01 · FY2018 · CA
Mesenchymal Stem Cells to Repair Chemobrain$402,051
R01 · FY2018 · CA · contact PI
Mesenchymal Stem Cells to Repair Chemobrain$378,550
R01 · FY2018 · CA · contact PI
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$375,286
R01 · FY2018 · NS
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain$366,766
R01 · FY2018 · CA
Mesenchymal Stem Cells to Repair Chemobrain$402,051
R01 · FY2017 · CA · contact PI
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$375,286
R01 · FY2017 · NS
Mesenchymal Stem Cells to Repair Chemobrain$402,051
R01 · FY2016 · CA · contact PI
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$375,286
R01 · FY2016 · NS
Targeting Neural Mitochondria to Treat Chemotherapy-Induced Peripheral Neuropathy$174,000
R21 · FY2015 · CA · contact PI
Targeting Neural Mitochondria to Treat Chemotherapy-Induced Peripheral Neuropathy$208,800
R21 · FY2014 · CA · contact PI